Literature DB >> 16534420

Racial differences in disease phenotypes in patients with Crohn's disease.

Raymond K Cross1, Carrianne Jung, Sharmeel Wasan, Grishma Joshi, Robert Sawyer, Mary-Claire Roghmann.   

Abstract

BACKGROUND: Our objectives were to assess the differences in perforating disease behavior, disease severity, and extraintestinal manifestations (EIM) in patients with Crohn's disease (CD) by race.
MATERIALS AND METHODS: We identified outpatients with CD evaluated at the University of Maryland Gastroenterology Faculty Practice office or the Baltimore Veterans Affairs Maryland Health Care System, from 1997 to 2005. We assessed age at diagnosis, disease behavior, disease location, need for surgery and EIM.
RESULTS: Race was not associated with perforating disease behavior (relative risk [RR] 0.79, 95% confidence interval [CI] 0.46-1.35), need for surgery (RR 0.89, 95% CI 0.56-1.12), and EIM of CD (RR 0.77, 95% CI 0.46-1.27). White patients were significantly more likely to have ileal disease, whereas African American patients were significantly more likely to have ileocolonic and colonic disease. Age at diagnosis younger than 40 years (odds ratio [OR] 4.41, 95% CI 1.84-10.56) and ileocolonic disease (OR 2.39, 95% CI 1.24-4.63) were independent risk factors for perforating disease behavior. Similarly, age at diagnosis younger than 40 (OR 2.79, 95% CI 1.45-5.33), ileal disease (OR 3.76, 95% CI 1.66-8.48), and ileocolonic disease (OR 2.57, 95% CI1.21-5.46) were associated with the need for surgery. Female gender (OR 4.23, 95% CI 1.87-9.58) and a positive family history of CD (OR 3.45, 95% CI 1.49-8.0) were associated with joint manifestations of CD. DISCUSSION: We did not detect differences in disease behavior, severity, or joint EIM by race. Although African American patients were more likely to have ileocolonic or colonic disease, these factors did not affect disease behavior or severity.

Entities:  

Mesh:

Year:  2006        PMID: 16534420     DOI: 10.1097/01.MIB.0000217767.98389.20

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  17 in total

1.  Predictors of aggressive inflammatory bowel disease.

Authors:  Andres J Yarur; Sebastian G Strobel; Amar R Deshpande; Maria T Abreu
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-10

Review 2.  Systematic review: The role of race and socioeconomic factors on IBD healthcare delivery and effectiveness.

Authors:  Justin L Sewell; Fernando S Velayos
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

3.  Patient-reported outcomes in Crohn's disease: does race matter?

Authors:  Sara Horst
Journal:  Dig Dis Sci       Date:  2014-08-12       Impact factor: 3.199

4.  A comparison of abdominal surgical outcomes between African-American and Caucasian Crohn's patients.

Authors:  Nicole Griglione; Shadi Yarandi; Jahnavi Srinivasan; Thomas Ahearn; Tanvi Dhere
Journal:  Int J Colorectal Dis       Date:  2014-05-15       Impact factor: 2.571

5.  Racial differences in disease activity and quality of life in patients with Crohn's disease.

Authors:  Leyla J Ghazi; Alison D Lydecker; Seema A Patil; Ankur Rustgi; Raymond K Cross; Mark H Flasar
Journal:  Dig Dis Sci       Date:  2014-04-10       Impact factor: 3.199

6.  IBD Serology and Disease Outcomes in African Americans With Crohn's Disease.

Authors:  Madeline Bertha; Arthi Vasantharoopan; Archana Kumar; Beau B Bruce; Jarod Prince; Tatyana Hofmekler; David Okou; Pankaj Chopra; Gabriel Wang; Cary Sauer; Carol J Landers; Sunny Z Hussain; Raymond K Cross; Robert N Baldassano; Michael D Kappelman; Jeffrey Katz; Jonathan S Alexander; Barbara S Kirschner; Dedrick E Moulton; Bankole O Osuntokun; Ashish Patel; Shehzad Saeed; Jan-Michael A Klapproth; Tanvi A Dhere; Marla C Dubinsky; Dermot McGovern; Subra Kugathasan
Journal:  Inflamm Bowel Dis       Date:  2017-12-19       Impact factor: 5.325

7.  Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Studies.

Authors:  Hai Yun Shi; Alexander N Levy; Hirsh D Trivedi; Francis K L Chan; Siew C Ng; Ashwin N Ananthakrishnan
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-08       Impact factor: 11.382

8.  Crohn's disease in one mixed-race population in Brazil.

Authors:  Genoile Oliveira Santana; Luiz Guilherme Costa Lyra; Tamara Celi Almeida Santana; Lidiane Bianca Dos Reis; Jorge Carvalho Guedes; Maria Betania Toralles; André Castro Lyra
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

9.  Genome-wide SNP typing reveals signatures of population history.

Authors:  Austin L Hughes; Robert Welch; Vinita Puri; Casey Matthews; Kashif Haque; Stephen J Chanock; Meredith Yeager
Journal:  Genomics       Date:  2008-05-16       Impact factor: 5.736

10.  NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African Americans.

Authors:  Themistocles Dassopoulos; Geoffrey C Nguyen; Monica Vladut Talor; Lisa Wu Datta; Kim L Isaacs; James D Lewis; Michael S Gold; John F Valentine; Duane T Smoot; Mary L Harris; Maria Oliva-Hemker; Theodore M Bayless; C Lynne Burek; Steven R Brant
Journal:  Am J Gastroenterol       Date:  2009-10-13       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.